Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy

被引:0
|
作者
Takayuki Ando
Ayumu Hosokawa
Shinya Kajiura
Yuko Itaya
Akira Ueda
Haruka Fujinami
Jun Nishikawa
Takashi Kobayashi
Naoki Horikawa
Yuji Tsukioka
Kazuhisa Yabushita
Masayuki Note
Kohei Ogawa
Toshiro Sugiyama
机构
[1] University of Toyama,Department of Gastroenterology and Hematology, Faculty of Medicine
[2] Takaoka City Hospital,Department of Surgery
来源
Gastric Cancer | 2012年 / 15卷
关键词
Gastric cancer; Weekly paclitaxel; Docetaxel; Cross-resistance; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:427 / 432
页数:5
相关论文
共 50 条
  • [1] Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy
    Ando, Takayuki
    Hosokawa, Ayumu
    Kajiura, Shinya
    Itaya, Yuko
    Ueda, Akira
    Fujinami, Haruka
    Nishikawa, Jun
    Kobayashi, Takashi
    Horikawa, Naoki
    Tsukioka, Yuji
    Yabushita, Kazuhisa
    Note, Masayuki
    Ogawa, Kohei
    Sugiyama, Toshiro
    GASTRIC CANCER, 2012, 15 (04) : 427 - 432
  • [2] Efficacy of weekly paclitaxel in patients with advanced gastric cancer with prior docetaxel-containing chemotherapy.
    Ando, Takayuki
    Hosokawa, Ayumu
    Ogawa, Kohei
    Kajiura, Shinya
    Itaya, Yuko
    Ueda, Akira
    Tsukioka, Yuji
    Kobayashi, Takashi
    Horikawa, Naoki
    Sugiyama, Toshiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Use of class III beta tubulin to predict efficacy from paclitaxel- or docetaxel-based chemotherapy in patients with advanced gastric cancer.
    Ahn, J.
    Jung, M.
    Chang, H.
    Zhang, X.
    Jeung, H.
    Kim, T.
    Roh, J. K.
    Chung, H. C.
    Rha, S. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [4] Docetaxel-based chemotherapy in the treatment of gastric cancer
    Roth, AD
    Ajani, J
    ANNALS OF ONCOLOGY, 2003, 14 : 41 - 44
  • [5] Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer
    Roberto Biffi
    Nicola Fazio
    Fabrizio Luca
    Antonio Chiappa
    Bruno Andreoni
    Maria Giulia Zampino
    Arnaud Roth
    Jan Christian Schuller
    Giancarla Fiori
    Franco Orsi
    Guido Bonomo
    Cristiano Crosta
    Olivier Huber
    World Journal of Gastroenterology, 2010, 16 (07) : 868 - 874
  • [6] Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer
    Biffi, Roberto
    Fazio, Nicola
    Luca, Fabrizio
    Chiappa, Antonio
    Andreoni, Bruno
    Zampino, Maria Giulia
    Roth, Arnaud
    Schuller, Jan Christian
    Fiori, Giancarla
    Orsi, Franco
    Bonomo, Guido
    Crosta, Cristiano
    Huber, Olivier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (07) : 868 - 874
  • [7] Paclitaxel versus docetaxel-based neoadjuvant chemotherapy and risk of lymphedema in breast cancer patients.
    Zhu, Yirong
    Abdelrhman, Tamer Refaat
    Ho, Yvonne D.
    Thomas, Tarita
    Small, William
    Godellas, Constantine
    Vaince, Faaiza
    Mai, Hanh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Weekly Paclitaxel as Second-line Chemotherapy in Japanese Patients with Advanced Gastric Cancer
    Kadokura, Makoto
    Iwasa, Satoru
    Honma, Yoshitaka
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Enomoto, Nobuyuki
    Shimada, Yasuhiro
    ANTICANCER RESEARCH, 2013, 33 (10) : 4547 - 4552
  • [9] A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer
    Graziano, F
    Catalano, V
    Baldelli, AM
    Giordani, P
    Testa, E
    Lai, V
    Catalano, G
    Battelli, N
    Cascinu, S
    ANNALS OF ONCOLOGY, 2000, 11 (10) : 1263 - 1266
  • [10] Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer
    Yasufuku, Tomihiko
    Shigemura, Katsumi
    Matsumoto, Osamu
    Arakawa, Soichi
    Fujisawa, Masato
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (03) : 200 - 205